EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome

Aimi Owaki, Shota Kaseda, Shunsuke Tanigawa, Koichiro Miike, Yuya Sannomiya, Haruki Tsuhako, Ryoichi Sato, Keito Mizumoto, Jun Horizono, Ryo Kumabe, Midori Tokuyasu, Yukio Fujiwara und 8 weitere

Journal of Pharmacological Sciences · 2026

DOI: 10.1016/j.jphs.2026.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacological Sciences, 2026. Verfasst von Aimi Owaki und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Nephritis, Hereditary, Proteinuria, Up-Regulation, Tumor Necrosis Factor Ligand Superfamily Member 15. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Kidney Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alport syndrome is a progressive kidney disease caused by pathogenic variants in genes encoding type IV collagen, a major structural component of the glomerular basement membrane (GBM). Abnormal GBM architecture impairs filtration and triggers inflammation, fibrosis, and eventual kidney failure. Because disease progression is irreversible, identifying early molecular changes is essential for understanding disease onset. We performed glomerular single-cell RNA sequencing (scRNA-seq) in a Col4a5 G5X Alport mouse model at 5 weeks of age, prior to detectable proteinuria or GBM/podocyte abnormalities (pre-onset), and at 8 weeks, when mild proteinuria and structural defects emerged. Despite the early stage, scRNA-seq revealed widespread transcriptional alterations, most prominently in podocytes. Among genes upregulated at both time points, we identified Tumor Necrosis Factor Superfamily Member 15 (Tnfsf15), previously associated with kidney disease susceptibility but with unclear function. To determine its role in Alport syndrome, we generated Tnfsf15-deficient Alport mice. Tnfsf15 homozygous knockout mice exhibited increased proteinuria and exacerbated glomerular injury compared with Tnfsf15(+/+) Alport mice during early disease. These findings support a protective role for Tnfsf15 in the early stages of Alport syndrome, mitigating proteinuria and limiting glomerular injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephritis, HereditaryProteinuriaUp-RegulationTumor Necrosis Factor Ligand Superfamily Member 15Kidney GlomerulusAnimalsDisease Models, AnimalMice, KnockoutCollagen Type IVPodocytesDisease ProgressionMice

Stichwörter der Autor:innen

Alport syndromeEarly-stage diseaseGlomerular diseaseSingle cell RNA-seqTnfsf15

Substanzen

Tumor Necrosis Factor Ligand Superfamily Member 15Collagen Type IV

Autor:innen und Institutionen

  • Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan; Wellcome Centre for Cell-Matrix Research, University of Manchester, Manchester, M13 9PT, United Kingdom.
  • Department of Kidney Development, Institute of Molecular Embryology and Genetics, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.
  • Division of Developmental Genetics, Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan.
  • Department of Cell Pathology, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Division of Reproductive Engineering, Center for Animal Resources and Development, Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Kumamoto, 860-0811, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Kidney Research UK
  • University of Manchester
  • Ministry of Education, Culture, Sports, Science and Technology
  • Kumamoto University

Zitieren

APA

Owaki, A., Kaseda, S., Tanigawa, S., Miike, K., Sannomiya, Y., Tsuhako, H., Sato, R., Mizumoto, K., Horizono, J., Kumabe, R., Tokuyasu, M., Fujiwara, Y., Takeo, T., Araki, K., Davenport, B., Lennon, R., Shuto, T., Nishinakamura, R., Suico, M. A., & Kai, H. (2026). Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome. Journal of Pharmacological Sciences. https://doi.org/10.1016/j.jphs.2026.01.005

Vancouver

Owaki A, Kaseda S, Tanigawa S, Miike K, Sannomiya Y, Tsuhako H, et al. Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome. Journal of Pharmacological Sciences. 2026. doi:10.1016/j.jphs.2026.01.005

BibTeX
@article{Owaki2026,
  author = {Owaki, Aimi and Kaseda, Shota and Tanigawa, Shunsuke and Miike, Koichiro and Sannomiya, Yuya and Tsuhako, Haruki and Sato, Ryoichi and Mizumoto, Keito and Horizono, Jun and Kumabe, Ryo and Tokuyasu, Midori and Fujiwara, Yukio and Takeo, Toru and Araki, Kimi and Davenport, Bernard and Lennon, Rachel and Shuto, Tsuyoshi and Nishinakamura, Ryuichi and Suico, Mary Ann and Kai, Hirofumi},
  title = {Protective role of early Tnfsf15 upregulation in limiting glomerular injury and proteinuria in experimental Alport Syndrome},
  journal = {Journal of Pharmacological Sciences},
  year = {2026},
  doi = {10.1016/j.jphs.2026.01.005}
}
Kostenlos starten →